Related Experiment Video
Updated: Jun 12, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Heterozygosity for Pten promotes tumorigenesis in a mouse model of medulloblastoma
Robert C Castellino1, Benjamin G Barwick, Matthew Schniederjan
1Department of Pediatrics, Aflac Cancer Center and Blood Disorders Service, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA. rccaste@emory.edu
Background:
Recent publications have described an important role for cross talk between PI-3 kinase and sonic hedgehog signaling pathways in the pathogenesis of medulloblastoma.
Methodology/Principal Findings:
We crossed mice with constitutive activation of Smoothened, SmoA1, with Pten deficient mice. Both constitutive and conditional Pten deficiency doubled the incidence of mice with symptoms of medulloblastoma and resulted in decreased survival. Analysis revealed a clear separation of gene signatures, with up-regulation of genes in the PI-3 kinase signaling pathway, including downstream activation of angiogenesis in SmoA1+/-; Pten +/- medulloblastomas. Western blotting and immunohistochemistry confirmed reduced or absent Pten, Akt activation, and increased angiogenesis in Pten deficient tumors. Down-regulated genes included genes in the sonic hedgehog pathway and tumor suppressor genes. SmoA1+/-; Pten +/+ medulloblastomas appeared classic in histology with increased proliferation and diffuse staining for apoptosis. In contrast, Pten deficient tumors exhibited extensive nodularity with neuronal differentiation separated by focal areas of intense staining for proliferation and virtually absent apoptosis. Examination of human medulloblastomas revealed low to absent PTEN expression in over half of the tumors. Kaplan-Meier analysis confirmed worse overall survival in patients whose tumor exhibited low to absent PTEN expression.
Conclusions/Significance:
This suggests that PTEN expression is a marker of favorable prognosis and mouse models with activation of PI-3 kinase pathways may be important tools for preclinical evaluation of promising agents for the treatment of medulloblastoma.
Insights
PTEN deficiency in mice significantly increases medulloblastoma incidence and decreases survival by activating PI-3 kinase pathways. Low PTEN expression in human tumors correlates with worse survival, suggesting PTEN as a prognostic marker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cross talk between PI-3 kinase and sonic hedgehog pathways is implicated in medulloblastoma pathogenesis.
- PTEN (Phosphatase and tensin homolog) plays a critical role in cellular signaling.
- Medulloblastoma is a common malignant brain tumor in children.
Purpose of the Study:
- To investigate the role of PTEN deficiency in medulloblastoma development.
- To explore the interplay between PI-3 kinase and sonic hedgehog pathways in PTEN-deficient medulloblastoma.
- To evaluate PTEN expression as a prognostic marker in human medulloblastoma.
Main Methods:
- Generated genetically engineered mouse models by crossing SmoA1 mice with Pten deficient mice.
- Analyzed gene expression profiles, performed Western blotting, and immunohistochemistry on tumor samples.
- Examined PTEN expression and survival data in human medulloblastoma patient cohorts.
Main Results:
- Pten deficiency in mice doubled medulloblastoma incidence and reduced survival.
- Pten deficient tumors showed activation of PI-3 kinase pathway, increased angiogenesis, and altered gene signatures.
- Low or absent PTEN expression in human medulloblastomas correlated with significantly worse overall survival.
Conclusions:
- PTEN deficiency promotes medulloblastoma through PI-3 kinase pathway activation.
- PTEN expression serves as a favorable prognostic marker in medulloblastoma.
- Mouse models with activated PI-3 kinase pathways are valuable for preclinical drug evaluation.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Abnormal Proliferation